Prospective Study of Patients With Thrombocytopenia Following HSCT

PHASE3CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 12, 2019

Study Completion Date

April 12, 2019

Conditions
ThrombocytopeniaHematologic Diseases
Interventions
DRUG

Decitabine

Decitabine

DRUG

rhTPO

rhTPO

OTHER

Conventional Treatment

immunoglobulin, glucocorticoid etc

Trial Locations (1)

215000

The First affiliated Hospital of SooChow University, Suzhou

All Listed Sponsors
collaborator

Peking University People's Hospital

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Ruijin Hospital

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Children's Hospital of Soochow University

OTHER

collaborator

Fujian Medical University Union Hospital

OTHER

collaborator

Hebei Yanda Ludaopei Hospital

OTHER

lead

The First Affiliated Hospital of Soochow University

OTHER

NCT02487563 - Prospective Study of Patients With Thrombocytopenia Following HSCT | Biotech Hunter | Biotech Hunter